Table 3 Summary of response to chemotherapy in reported cases of urachal carcinoma
Reference | Number of patients | Chemotherapy and status at last follow-up | Response | Follow-up result |
|---|---|---|---|---|
[18] | 1 | Paclitaxel and carboplatin | Stable | Alive with disease (3Â months) |
[19] | 1 | 5-flourouracil, cisplatin, and gemcitabine | Complete response | Died of disease (38Â months) |
[20] | 1 | 5-fluorouracil, folinic acid, and oxaliplatin | Complete response | Died of disease (26Â months) |
[28] | 3 | 5-fluorouracil, doxorubicin, and mitomycin C | Partial response | Died of disease (12Â months) |
[29] | 1 | 5-fluorouracil, mitomycin C, and mitoxantrone, | Complete response | Died of disease (28Â months) |
[21] | Patient 1 | 5-fluorouracil, doxorubicin, and cisplatin; | Complete response | Alive without disease (11Â years) |
5-fluorouracil, doxorubicin, and etoposide; | ||||
5-fluorouracil, cisplatin, and α interferon | ||||
[21] | Patient 2 | Doxorubicin, cisplatin, and mitomycin C | Complete response | Alive without disease (10Â years) |
[22] | 1 | Docetaxel and carboplatin | Complete response | Alive with disease (36Â months) |
[30] | 1 | Tegafur, gimeracil, oteracil, and cisplatin | Complete response | Alive without disease (30Â months) |
[31] | 1 | Cisplatin, Adriamycin, vinblastine, and methotrexate | Partial response | Alive with disease (13Â months) |